Image

Global Platelet Rich Plasma Market - Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Apr 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Platelet Rich Plasma Market, By Type (Pure Platelet Rich Plasma, Leukocyte-Rich Platelet Rich Plasma, Leukocyte-Rich Fibrin, Others), Origin (Allogeneic Platelet Rich Plasma, Autologous Platelet Rich Plasma, Homologous Platelet Rich Plasma), Application (Cosmetic Surgery and Aesthetics, General Surgery, Neurosurgery, Orthopedic and Spinal Surgery, Others), End User (Hospitals and Clinics, Research Institutes, Others) - Industry Trends and Forecast to 2029

 

Platelet Rich Plasma Market

Market Analysis and Size          

Platelet rich plasma has been widely used in clinical settings in recent years. It has gained a lot of traction in the world of cosmetic surgery. Plastic surgeons and dermatologists are using platelets' natural healing properties to improve the appearance and overall health of the skin. Several research studies have evaluated the use of Platelet Rich Plasma for facial rejuvenation, with positive aesthetic outcomes.

The pure platelet rich plasma segment is expected to account for a significant portion of the platelet rich plasma market. The segment's dominance can be attributed to technological advancements in platelet rich plasma devices, which have resulted in the use of pure platelet rich plasma in a variety of cases and a high platelet content. Data Bridge Market Research analyses that the platelet rich plasma market was valued at USD 535.61 million in 2021 and is further estimated to reach USD 1374.27 million by 2029, and is expected to grow at a CAGR of 12.5% during the forecast period of 2022 to 2029.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Type (Pure Platelet Rich Plasma, Leukocyte-Rich Platelet Rich Plasma, Leukocyte-Rich Fibrin, Others), Origin (Allogeneic Platelet Rich Plasma, Autologous Platelet Rich Plasma, Homologous Platelet Rich Plasma), Application (Cosmetic Surgery and Aesthetics, General Surgery, Neurosurgery, Orthopedic and Spinal Surgery, Others), End User (Hospitals and Clinics, Research Institutes, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Ycellbio Medical Co., Ltd. (South Korea), Zimmer Biomet (US), Stryker Corporation (US), ROCKY MOUNTAIN BIOLOGICALS (US), Regen Lab SA (Switzerland), TERUMO BCT, INC. (US), GLOFINN (Finland), ExaTech Inc. (US), EmCyte Corporation(US), ThermoGenesis Holdings, Inc. (US), Octapharma Brasil Ltda (Brazil), Dr PRP USA LLC (US), Isto Biologics (US), Arthrex, Inc. (US), Terumo Corporation (Japan), Cascade Medical. (US), Grifols, S.A. (Spain), Johnson & Johnson Private Limited (US)

Market Opportunities

  • Increase in the breadth and use of PRP therapy across Medicare beneficiaries
  • Extending medical applications of platelet rich plasma

Market Definition

Blood is used to create platelet rich plasma (PRP). It is created when human blood is spun down and platelet rich plasma with platelet concentrations above normal values is separated. Platelets aid in blood clotting and the healing of tendons, muscles, and ligaments.

Platelet Rich Plasma Market Dynamics                                          

Drivers

Major factors that are expected to boost the growth of the platelet rich plasma market in the forecast period are as follows:

  • Rise in the prevalence of sports injuries

Sports-related injuries have increased over the last two decades. Knee, elbow, and shoulder injuries are the most common sports injuries in softball and baseball players which will further accelerate the market growth.

  • Growing number of cosmetic surgical procedures

The number of cosmetic surgical procedures performed has increased over the last five years, as has people's preference for minimally invasive cosmetic surgery. Liposuction and facelifts are becoming increasingly popular which is further anticipated to propel the growth of the platelet rich plasma market.

  • Technological developments

Technological advancements in platelet rich plasma devices, which have led to an increase in the use of pure platelet rich plasma in various situations and high platelet concentration. The industry has also benefited from technological breakthroughs such as smart home diagnostic kits which is expected to drive the market.

Opportunities

In addition, the rise in the in the awareness related platelet rich plasma therapies is further estimated to provide potential opportunities for the growth of the platelet rich plasma market in the coming years.

Restraints/Challenges

On the other hand, the increased volatilization in the price of platelet-rich plasma therapy is further projected to impede the growth of the platelet rich plasma market in the targeted period. However, the difficulties regarding the quality control and test results might further challenge the growth of the platelet rich plasma market in the near future.

This platelet rich plasma market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the platelet rich plasma market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 Impact on Platelet Rich Plasma Market

The pandemic of COVID-19 has had a huge impact on the platelet rich plasma market. The unexpected outbreak has had a positive impact on market growth. Due to a lack of antiviral therapies and the fact that plasma therapy is considered an emergency treatment method, the COVID-19 pandemic has helped to expand the market. One of the advantages of platelet-rich plasma is that it can be used to relieve pain during COVID-19. However, in the post-COVID scenario, there is a growing demand for platelet rich plasma.

Recent Development

  • In February 2021, Atlas Health Medical Group had announced platelet rich plasma availability micro-needling Facelifts to patients.

Global Platelet Rich Plasma Market Scope and Market Size

The platelet rich plasma market is segmented on the basis of type, origin, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Pure Platelet Rich Plasma
  • Leukocyte-Rich Platelet Rich Plasma
  • Leukocyte-Rich Fibrin
  • Others

On the basis of type, the platelet rich plasma market is segmented into pure platelet rich plasma, leukocyte-rich platelet rich plasma, leukocyte-rich fibrin and others.

Origin

  • Allogeneic Platelet Rich Plasma
  • Autologous Platelet Rich Plasma
  • Homologous Platelet Rich Plasma

On the basis of origin, the platelet rich plasma market is segmented into allogeneic platelet rich plasma, autologous platelet rich plasma and homologous platelet rich plasma.

Application

  • Cosmetic Surgery and Aesthetics
  • General Surgery
  • Neurosurgery
  • Orthopedic and Spinal Surgery
  • Others

On the basis of application, the platelet rich plasma market is segmented into cosmetic surgery and aesthetics, general surgery, neurosurgery, orthopedic and spinal surgery and others. Others have been further sub segmented into urology, cardiothoracic surgery, oral and maxillofacial surgery, periodontal surgery, otorhinolaryngology-head and neck surgery.

End user                                  

  • Hospitals and Clinics
  • Research Institutes
  • Others

On the basis of end user, the platelet rich plasma market is segmented into hospitals, and clinics, research institutes and others.

Platelet Rich Plasma Market Regional Analysis/Insights

The platelet rich plasma market is analysed and market size insights and trends are provided by country, type, origin, application and end user as referenced above.

The countries covered in the platelet rich plasma market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the platelet rich plasma market due to the rise in the incidence of chronic disorders. Furthermore, the well-settled healthcare infrastructure will further boost the growth of the platelet rich plasma market in the region during the forecast period.

Asia-Pacific is projected to observe significant amount of growth in the platelet rich plasma market due to the increase in the government support. Moreover, the rise in the elderly population will further boost the growth of the platelet rich plasma market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The platelet rich plasma market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for platelet rich plasma market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the platelet rich plasma market. The data is available for historic period 2010-2020.

Competitive Landscape and Platelet Rich Plasma Market Share Analysis

The platelet rich plasma market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to platelet rich plasma market.

 Some of the major players operating in the platelet rich plasma market are:

  • Ycellbio Medical Co., Ltd. (South Korea)
  • Zimmer Biomet (US)
  • Stryker Corporation (US)
  • ROCKY MOUNTAIN BIOLOGICALS (US)
  • Regen Lab SA (Switzerland)
  • TERUMO BCT, INC. (US)
  • GLOFINN (Finland)
  • ExaTech Inc. (US)
  • EmCyte Corporation(US)
  • ThermoGenesis Holdings, Inc. (US)
  • Octapharma Brasil Ltda (Brazil)
  • Dr PRP USA LLC (US)
  • Isto Biologics (US)
  • Arthrex, Inc. (US)
  • Terumo Corporation (Japan)
  • Cascade Medical. (US)
  • Grifols, S.A. (Spain)
  • Johnson & Johnson Private Limited (US)

Research Methodology: Global Platelet Rich Plasma Market                                                  

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The market value for Platelet Rich Plasma Market is expected USD 1374.27 million by 2029.
The Platelet Rich Plasma Market is to grow at a CAGR of 12.5% during the forecast by 2029.
On the basis of application, the Platelet Rich Plasma Market is segmented into Cosmetic Surgery and Aesthetics, General Surgery, Neurosurgery, Orthopedic and Spinal Surgery, Others.
The major players operating in the Platelet Rich Plasma Market are Ycellbio Medical Co., Ltd. (South Korea), Zimmer Biomet (US), Stryker Corporation (US), ROCKY MOUNTAIN BIOLOGICALS (US), Regen Lab SA (Switzerland), TERUMO BCT, INC. (US), GLOFINN (Finland), ExaTech Inc. (US), EmCyte Corporation(US), ThermoGenesis Holdings, Inc. (US), Octapharma Brasil Ltda (Brazil), Dr PRP USA LLC (US), Isto Biologics (US), Arthrex, Inc. (US), Terumo Corporation (Japan), Cascade Medical. (US), Grifols, S.A. (Spain), Johnson & Johnson Private Limited (US).